Robert Hoyt has joined GenomeQuest's board of directors
Hoyt is currently Eximo's chief operating officer. Prior to that, he was the general manager of Endeca Technologies which sold to Oracle in 2011.
Software vendors attempting to tap into the nascent clinical sequencing market are taking steps to ensure that their offerings toe the lines set by federal agencies to ensure the privacy and security of patient information.
GenomeQuest has completed an integration agreement with online information services firm Questel that allows researchers to review biological sequence patents from GenomeQuest's GQ-IP system via Questel's Orbit platform, an IP da
By Bernadette Toner
GenomeQuest this week said that the Emory Genetics Laboratory is using its GQ-Dx software to support a suite of sequencing-based diagnostic tests it offers through its CLIA-certified facility.
GenomeQuest said this week that it is awarding software and services worth more than $120,000 to six laboratories in order to help them transition Sanger-based gene tests to next-generation sequencing platforms.